Doctor profile · Federal record
Dr. Philip Gold, MD
Medical Oncology Physician (CMS: Internal Medicine) · Seattle, WA
- NPI 1265516983
- Accepts Medicare
- MIPS 82.8 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1221 Madison St Fl 2
Seattle, WA 981043588
(206) 386-2323
fax (206) 215-6165 - Mailing address
-
Po Box 25608
Salt Lake City, UT 841250608
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- February 27, 2026
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Washington #MD00031062
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1265516983. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
448
Distinct HCPCS
5
Medicare allowed
$51,437
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 226 | 62 | $104 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 119 | 38 | $154 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 55 | 42 | $70 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 32 | 13 | $78 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 16 | 16 | $195 |
In context: peer comparison
Among 18 peers in Seattle Medical Oncology Physician, average services per provider: 51. This provider delivers 8.8× the peer median.Open Payments
Industry payments received
All-time total
$160
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 1 | $131.57 | |
| OsteoCentric Technologies, INC. | 1 | $28.58 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
291
Patients
65
Total drug cost
$706,288
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Potassium Chloride | Generic | 64 | 17 | $2,077 |
| Imatinib Mesylate | Generic | 40 | 0 | $126,763 |
| Ondansetron Odt (Ondansetron) | Brand | 38 | 23 | $521 |
| Prochlorperazine Maleate | Generic | 36 | 25 | $404 |
| Pantoprazole Sodium | Generic | 20 | 0 | $177 |
| Diphenoxylate-Atropine (Diphenoxylate Hcl/Atropine) | Brand | 17 | 0 | $218 |
| Xarelto (Rivaroxaban) | Brand | 16 | 0 | $11,166 |
| Lynparza (Olaparib) | Brand | 13 | 0 | $220,987 |
| Lenvima (Lenvatinib Mesylate) | Brand | 12 | 0 | $291,717 |
| Lisinopril | Generic | 12 | 0 | $256 |
Hospital affiliations
Frequently asked questions
What is Dr. Philip Gold's medical specialty?
Dr. Philip Gold practices Medical Oncology Physician in Seattle, WA.
Where does Dr. Philip Gold practice?
Dr. Philip Gold practices at 1221 Madison St Fl 2, Seattle, WA 981043588. Office phone: 2063862323.
What is Dr. Philip Gold's NPI?
Dr. Philip Gold's National Provider Identifier (NPI) is 1265516983, issued by NPPES.
Does Dr. Philip Gold accept Medicare assignment?
Yes. Dr. Philip Gold accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Philip Gold commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.